Effects of Kegel Exercises and Myokinetic Release of Trigger Points in Primary Dysmenorrhea (NCT06777940) | Clinical Trial Compass
RecruitingNot Applicable
Effects of Kegel Exercises and Myokinetic Release of Trigger Points in Primary Dysmenorrhea
Pakistan50 participantsStarted 2023-12-23
Plain-language summary
The rationale of this study is despite the widespread belief that exercise can reduce dysmenorrhea, evidence-based studies are limited. Studies are therefore required to evaluate the association between quality of life and the primary dysmenorrheal females, the functional impact on the quality of life and primary dysmenorrhea females also it's a crucial time for females to focus on their studies and dysmenorrhea can add to the fatigue levels and cause distress in this age group thus the purpose of this study is to determine whether myokinetic active release of trigger points in the rectus abdominis, gluteus medius and quadratus lumborum is a more effective way to reduce dysmenorrhea than kegel exercises
Who can participate
Age range
17 Years – 25 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age 17-25 years
* Diagnosed cases of dysmenorrhea
* Subject having trigger point in rectus abdominins, quadratus lumborum and gluteus medius
* With regular cycles 21-35 days lasting 3-7 days
Exclusion Criteria:
* Oral contraceptives used for menstrual irregularity
* Other gynecological disease like fibroids, endometriosis
* Who take analgesia
* Endometrial polyp, having pelvic infection using IUD, having venous congestion in internal genital organs.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
pain is assessed by numerical pain rating scale
Timeframe: at baseline pre intervention, at the end of 8 week post intervention
2
FSS scale is used to access fatigue severity
Timeframe: at baseline pre intervention, at the end of 8 week post intervention
3
SF-36 is used to access quality of life
Timeframe: at baseline pre intervention, at the end of 8 week post intervention